Research summary
AHK-Cu
A copper complex of the Ala-His-Lys tripeptide. Ex vivo and in vitro studies reported effects on human hair follicles and dermal papilla cells. Controlled human efficacy is not established.
Evidence at a glance
What the research says about AHK-Cu
The AHK-Cu evidence base cited here is 2 sources — 1 preclinical, 1 review. Critically, that evidence is almost entirely preclinical (animal and in-vitro) — no human clinical trials are cited, so efficacy and safety in people remain unproven.
Key findings
What the literature shows
- AHK-Cu is a copper complex of the tripeptide Ala-His-Lys.
- One study reported that AHK-Cu stimulated elongation of ex vivo human hair follicles and proliferation of cultured human dermal papilla cells.
- This evidence is ex vivo and in vitro. It does not establish a clinical hair-growth benefit in people.
Citations
2 peer-reviewed sources
All citations link to the original source (PubMed, journal site, or regulatory filing). Independent research database — no vendor influence on what's cited.
Preclinical1 source
Review1 source
Related research
